Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

BTK inhibitor PCI-32765 induces durable responses in relapsed or refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma

Prof Susan O’Brien - University of Texas MD Anderson Cancer Center, Houston
BTK inhibitor PCI-32765 induces durable responses in relapsed or refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma ( Prof Susan O’Brien - University of Texas MD Anderson Cancer Center, Houston )
9 Jan 2012

Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell non-hodgkin lymphoma (GAUSS)

Dr Laurie Sehn - University of British Columbia, Vancouver, Canada
Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell non-hodgkin lymphoma (GAUSS) ( Dr Laurie Sehn - University of British Columbia, Vancouver, Canada )
9 Jan 2012

ABVD chemo with radiation therapy for limited-stage hodgkin lymphoma

Dr Ralph Meyer - National Cancer Institute of Canada Clinical Trials Group
ABVD chemo with radiation therapy for limited-stage hodgkin lymphoma ( Dr Ralph Meyer - National Cancer Institute of Canada Clinical Trials Group )
9 Jan 2012

Two rituximab dosing strategies for low tumour burden follicular lymphoma (RESORT)

Prof Brad Kahl - University of Wisconsin, Madison, USA
Two rituximab dosing strategies for low tumour burden follicular lymphoma (RESORT) ( Prof Brad Kahl - University of Wisconsin, Madison, USA )
9 Jan 2012

Cereblon expression required for anti-myeloma activity of lenalidomide and pomalidomide

Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
Cereblon expression required for anti-myeloma activity of lenalidomide and pomalidomide ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
9 Jan 2012

Clinical research within developing countries

Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India
Clinical research within developing countries ( Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India )
20 Dec 2011

Results from the GeparQuinto trial

Dr Jens Huober - Kantonsspital St.Gallen, Breast Center, Switzerland
Results from the GeparQuinto trial ( Dr Jens Huober - Kantonsspital St.Gallen, Breast Center, Switzerland )
20 Dec 2011

Biological differences in breast cancer cases due to age

Dr Ann Partridge – Dana-Farber Cancer Institute, Boston, USA
Biological differences in breast cancer cases due to age ( Dr Ann Partridge – Dana-Farber Cancer Institute, Boston, USA )
20 Dec 2011

The latest for advanced breast cancer

Dr Hope Rugo – University of San Francisco, California USA
The latest for advanced breast cancer ( Dr Hope Rugo – University of San Francisco, California USA )
20 Dec 2011

The latest for Multiple Myeloma

Prof Paul Richardson - Dana Farber Institute, Boston, USA
The latest for Multiple Myeloma ( Prof Paul Richardson - Dana Farber Institute, Boston, USA )
19 Dec 2011

Myelodysplastic syndrome drug development and combination therapy

Prof Valeria Santini – University of Florence, Italy
Myelodysplastic syndrome drug development and combination therapy ( Prof Valeria Santini – University of Florence, Italy )
19 Dec 2011

Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI-32765

Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA
Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI-32765 ( Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA )
19 Dec 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation